1. Ascherio, A., K. L. Munger, E. T. Lennette, D. Spiegelman, M. A. Herman, J. Olek, S. E. Hankinson, and D. J. Hunter. 2001. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA26:3083-3088.
2. Betsou, F. 2006. Biobanks in immunoanalysis and specialized biology. Immunoanal. Biol. Spec.21:327-332.
3. Blake, N., T. Haigh, G. Shaka'a, D. Croom-Carter, and A. Rickinson. 2000. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from EBV nuclear antigen EBNA-1. J. Immunol.165:7078-7087.
4. Chaigneau, C., T. Cabioch, K. Beaumont, and F. Betsou. 2007. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clin. Chem. Lab Med.45:1390-1395.
5. Prevalence of Specific Antibodies to
Chlamydia pneumoniae
in Korea